![[Search]](/static/images/search.gif){kind=small}
![[A-Z Index]](/static/images/az.gif){kind=small}
![[Contact]](/static/images/contact.gif){kind=small}
![[University of Cambridge]](/static/images/identifier2.gif){kind=small}
![[Talks.cam]](/static/images/talkslogosmall.gif)
Dr Barry Davies, Global Project Leader, Oncology Combinations, Early Oncology, AstraZeneca.
Thursday 03 February 2022, 09:30-10:30
The AKT inhibitor Capivasertib (AZD5363): from discovery to clinical proof of concept
â ī¸ Important: This talk has been canceled/deleted
- đ¤ Speaker: Dr Barry Davies, Global Project Leader, Oncology Combinations, Early Oncology, AstraZeneca.
- đ Date & Time: Thursday 03 February 2022, 09:30 - 10:30
- đ Venue: William Harvey Lecture Theatre, School of Clinical Medicine
Questions? Contact
Justin Holt
Abstract
Abstract not available
Series This talk is part of the Cancer Research UK Cambridge Centre Lectures in Cancer Biology and Medicine series.
Included in Lists
This talk is not included in any other list.
Note: Ex-directory lists are not shown.